back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-05-16 16:54 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$127,764
+13,592 vol $9.40 each |
74,983 | |
| Filed 2022-05-16 16:53 Tx date 2022-05-10 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
97 - Other
|
$81,244
+8,643 vol $9.40 each |
61,391 | |
| Filed 2022-04-18 13:27 Tx date 2022-04-14 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-35,393.05
-1,595 vol $22.19 each |
24,617 | |
| Filed 2022-03-20 23:37 Tx date 2022-03-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-107,581.20
-4,846 vol $22.20 each |
26,212 | |
| Filed 2022-03-08 11:19 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-96,187.14
-4,074 vol $23.61 each |
31,058 | |
| Filed 2022-03-08 11:18 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$188,006
+7,963 vol $23.61 each |
35,132 | |
| Filed 2022-03-08 11:18 Tx date 2022-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-7,963 vol |
65,889 | |
| Filed 2022-03-04 16:55 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+131,910 vol |
323,356 | |
| Filed 2022-03-04 16:53 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
$861,104
+35,627 vol $24.17 each |
73,852 | |
| Filed 2022-03-04 16:52 Tx date 2022-03-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-37,275.15
-1,595 vol $23.37 each |
27,169 | |
| Filed 2022-03-03 18:36 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-40,201.85
-1,651 vol $24.35 each |
28,764 | |
| Filed 2022-03-03 18:35 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-39,641.80
-1,628 vol $24.35 each |
15,879 | |
| Filed 2022-03-03 18:34 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-137,480.10
-5,646 vol $24.35 each |
30,415 | |
| Filed 2022-03-03 18:33 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$111,206
+4,567 vol $24.35 each |
36,061 | |
| Filed 2022-03-03 18:33 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$109,623
+4,502 vol $24.35 each |
17,507 | |
| Filed 2022-03-03 18:32 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$380,225
+15,615 vol $24.35 each |
31,494 | |
| Filed 2022-03-03 18:31 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,567 vol |
38,225 | |
| Filed 2022-03-03 18:31 Tx date 2022-02-26 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-4,502 vol |
42,792 | |
| Filed 2022-03-03 18:29 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
57 - Exercise of rights
|
-15,615 vol |
52,748 | |
| Filed 2022-03-03 18:28 Tx date 2022-02-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+15,615 vol |
68,363 | |
| Filed 2022-02-17 17:15 Tx date 2022-02-15 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-81,340.02
-3,251 vol $25.02 each |
13,005 | |
| Filed 2022-01-21 11:03 Tx date 2022-01-18 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-86,574.13
-3,251 vol $26.63 each |
16,256 | |
| Filed 2021-10-05 18:15 Tx date 2021-10-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-8,093.80
-283 vol $28.60 each |
19,507 | |
| Filed 2021-10-05 18:14 Tx date 2021-10-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$23,023
+805 vol $28.60 each |
19,790 | |
| Filed 2021-10-05 18:13 Tx date 2021-10-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-805 vol |
47,294 | |
| Filed 2021-09-07 12:46 Tx date 2021-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+31,400 vol |
191,446 | |
| Filed 2021-09-07 12:44 Tx date 2021-09-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+9,026 vol |
48,099 | |
| Filed 2021-09-01 12:29 Tx date 2021-08-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-36,998.10
-1,278 vol $28.95 each |
18,985 | |
| Filed 2021-09-01 12:28 Tx date 2021-08-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$108,012
+3,731 vol $28.95 each |
20,263 | |
| Filed 2021-09-01 12:27 Tx date 2021-08-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,731 vol |
39,073 | |
| Filed 2021-03-05 19:07 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
56 - Grant of rights
|
+16,476 vol |
52,748 | |
| Filed 2021-03-05 19:06 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+32,749 vol |
160,046 | |
| Filed 2021-03-05 19:05 Tx date 2021-03-03 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
56 - Grant of rights
|
+23,892 vol |
42,804 | |
| Filed 2021-03-03 20:47 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-102,177.84
-3,252 vol $31.42 each |
16,532 | |
| Filed 2021-03-03 20:46 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$284,916
+9,068 vol $31.42 each |
19,784 | |
| Filed 2021-03-03 20:45 Tx date 2021-03-01 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-9,068 vol |
18,912 | |
| Filed 2020-10-06 17:25 Tx date 2020-10-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-4,385.64
-276 vol $15.89 each |
10,716 | |
| Filed 2020-10-06 17:24 Tx date 2020-10-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$12,775
+804 vol $15.89 each |
10,992 | |
| Filed 2020-10-06 17:23 Tx date 2020-10-02 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-804 vol |
27,980 | |
| Filed 2020-09-01 16:56 Tx date 2020-08-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
$-21,726
-1,278 vol $17.00 each |
10,188 | |
| Filed 2020-09-01 16:55 Tx date 2020-08-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$63,410
+3,730 vol $17.00 each |
11,466 | |
| Filed 2020-09-01 16:54 Tx date 2020-08-28 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
57 - Exercise of rights
|
-3,730 vol |
28,784 | |
| Filed 2020-06-02 19:53 Tx date 2020-05-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
127,297 | ||
| Filed 2020-06-02 19:51 Tx date 2020-05-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
36,272 | ||
| Filed 2020-06-02 19:50 Tx date 2020-05-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units (RSUs)
00 - Opening Balance-Initial SEDI Report
|
32,514 | ||
| Filed 2020-06-02 19:49 Tx date 2020-05-27 |
$BHC
Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.) |
Spurr, Robert Allen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
7,736 |